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Raouf A. Khalil, MD, PhD,a,b Boston and West Roxbury, Mass
Introduction:The vascular endothelium plays a major role in the control of arterial tone; however, its role in venous tissues
is less clear. The purpose of this study was to determine the role of endothelium in the control of venous function and the
relaxation pathways involved.
Methods:Circular segments of inferior vena cava (IVC) from male Sprague–Dawley rats were suspended between two wires
and isometric contraction to phenylephrine (Phe; 105M) and 96 mM KCl was measured. Acetylcholine (Ach; 1010 to
105M) was added and the percentage of venous relaxation was measured. To determine the role of nitric oxide (NO) and
prostacyclin (PGI2), vein relaxation was measured in the presence of the nitric oxide synthase inhibitor N-nitro-L-
arginine methyl ester (L-NAME; 3 104 M) and the cyclooxygenase inhibitor indomethacin (105 M). To measure the
role of hyperpolarization, vein relaxation was measured in the presence of K channel activator cromakalim (1011 to
106 M), and the nonselective K channel blocker tetraethylammonium (TEA; 103 M). To test for the contribution of
a specific K channel, the effects of K channel blockers: glibenclamide (adenosine triphosphate [ATP]-sensitive KATP,
105 M), 4-aminopyridine (4-AP; voltage-dependent Kv, 103 M), apamin (small conductance Ca2-dependent SKCa,
107 M), and iberiotoxin (large conductance Ca2-dependent BKCa, 108 M) on Ach-induced relaxation were tested.
Results: Ach caused concentration-dependent relaxation of Phe contraction (maximum 49.9  4.9%). Removal of
endothelium abolished Ach-induced relaxation. IVC treatment with L-NAME partially reduced Ach relaxation (32.8 
4.9%). In IVC treated with L-NAME plus indomethacin, significant Ach-induced relaxation (33.6 3.2%) could still be
observed, suggesting a role of endothelium-derived hyperpolarizing factor (EDHF). In IVC treated with L-NAME,
indomethacin and TEA, Ach relaxation was abolished, supporting a role of EDHF. In veins stimulated with high KCl,
Ach caused relaxation (maximum 59.5  3.5%) that was abolished in the presence of L-NAME and indomethacin
suggesting that any Ach-induced EDHF is blocked in the presence of high KCl depolarizing solution, which does not
favor outward movement of K ion and membrane hyperpolarization. Cromakalim, an activator of KATP, caused
significant IVC relaxation when applied alone or on top of maximal Ach-induced relaxation, suggesting that the Ach
response may not involve KATP. Ach-induced relaxation was not inhibited by glibenclamide, 4-AP, or apamin, suggesting
little role of KATP, Kv or SKCa, respectively. In contrast, iberiotoxin significantly inhibited Ach-induced relaxation,
suggesting a role of BKCa.
Conclusions: Thus, endothelium-dependent venous relaxation plays a major role in the control of venous function. In
addition to NO, an EDHF pathway involving BKCa may play a role in endothelium-dependent venous relaxation. (J Vasc
Surg 2012;55:1716-25.)
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Volume 55, Number 6 Raffetto et al 1717Clinical Relevance:Endothelial dysfunctionplays amajor role in thepathogenesis of arterial disease andcouldalso affect the course
of venous disease. Although the endothelium-derived mediators have been well characterized in the arterial wall, the mechanisms of
venous dilation are poorly understood. The present study in rat inferior vena cava, demonstrates that the mechanisms of venous
relaxation partly involve the nitric oxide (NO) pathway, as well as a significant portion involving the hyperpolarization pathway.
Although activation of ATP-sensitive K channels (KATP) could cause venous relaxation, Ach-induced endothelium-dependent
relaxation seems to involve the large conductance Ca2-dependent K channel (BKCa). The identification of the mechanisms of
venous relaxation could be important in the management of venous disease. Pharmacologic activators of the NO pathway and K
channels could be useful in reducing vein restenosis and graft failure. On the other hand, pharmacologic therapy using specific
blockers of the NO pathway and K channels could be useful in the management of primary and recurrent varicose veins.
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bThe vascular endothelium plays an important role in
regulating arterial tone, and endothelial dysfunction could
lead to progressive arterial disease such as hypertension and
atherosclerosis.1-4 An increase in shear stress on the endo-
thelium triggers the release of endothelium-derived sub-
stances, including nitric oxide (NO), prostacyclin (PGI2),
and endothelium-derived hyperpolarizing factor (EDHF).5-10
Endothelial NO diffuses into vascular smooth muscle cells
(VSMCs) where it activates guanylate cyclase and the NO-
cyclic guanosine monophosphate (cGMP) relaxation path-
way, whereas PGI2 activates adenylate cyclase and the
PGI2-cyclic adenosine monophosphate (cAMP) relaxation
pathway.11-13 In some arteries, particularly the small resis-
tance arteries, blocking the NO-cGMP pathway with the
NO synthase inhibitor N-nitro-L-arginine methyl ester
(L-NAME) and the PGI2-cAMP pathway with indometh-
acin does not completely inhibit endothelium-dependent
acetylcholine (Ach) relaxation, suggesting the release of
EDHF.8,12,14 EDHF could cause hyperpolarization of en-
dothelial cells, which propagates to VSMCs through myo-
endothelial gap junctions, or could cause the release of
diffusible factors from the endothelium, which act on
VSMCs leading to activation of K channels, hyperpolar-
ization, and vascular relaxation.1,8,15,16 Several types of K
channels have been identified in the vasculature, including
large conductance Ca2-activated (BKCa), intermediate
conductance Ca2-activated (IKCa), small conductance
Ca2-activated (SKCa), adenosine triphosphate (ATP)-
sensitive (KATP), voltage-gated (KV), and inward rectifier
(KIR).
8,16-18 The relative contribution of NO, PGI2, and
EDHF to arterial relaxation varies depending on the artery
size and specific arterial bed. For instance, NO is a major
factor in the relaxation of large arteries such as the
aorta.19-21 On the other hand, EDHF plays a major role in
relaxation of small resistance arteries such as the mesenteric
microvessels.22,23
Although the pathways of vascular relaxation have been
well-characterized in the arterial system, the role of NO-
cGMP, PGI2-cAMP, and EDHF in venous relaxation is less
defined.24-26 Also, while the majority of K channels have
been characterized in the arterial system, little is known
regarding the K channels involved in venous hyperpolar-
ization and relaxation. The purpose of this study was to
determine the role of the endothelium in the control of
venous function and the potential endothelium-dependent
venous relaxation pathways involved. sETHODS
Animals and tissues. Male Sprague-Dawley rats (12
eeks of age, 250-300 g in weight; Charles River Labora-
ories, Wilmington, Mass) were maintained on ad libitum
tandard rat chow and tap water in 12-hour/12-hour
ight/dark cycle. Rats were euthanized by inhalation of
arbon dioxide (CO2). The inferior vena cava (IVC) was
apidly excised, placed in oxygenated Krebs solution, and
arefully dissected and cleaned of connective tissue under
icroscopic visualization. The IVC was portioned into
-mm rings in preparation for isometric contraction exper-
ments. From each rat IVC, four 3-mm-wide segments
ere obtained. All vein segments were obtained from the
VC below the renal veins. Extreme care was taken
hroughout the tissue isolation and dissection procedure in
rder to minimize injury to the endothelium and the vein
all. One vein segment from each individual rat was used to
erform one experiment and obtain one set of data points.
umulative data from different vein segments from differ-
nt rats were used to calculate the average data for each arm
f the study. All procedures followed the National Insti-
utes of Health (NIH) guide for the Care of Laboratory
nimal Welfare Act and the guidelines of the Animal Care
nd Use Committee at Harvard Medical School.
Isometric contraction. Circular segments of IVC
ere suspended between two stainless-steel hooks; one
ook was fixed at the bottom of a tissue bath and the other
ook was connected to a Grass force displacement trans-
ucer (FT03; Astro-Med, West Warwick, RI). Vein seg-
ents were stretched under 0.5 g of resting tension and
llowed to equilibrate for 45 minutes in a tissue bath filled
ith 50-mL Krebs solution continuously bubbled with
5% O2 5% CO2 at 37°C. We have previously constructed
he relationship between basal tension and the contraction
o 96 mM KCl in rat IVC and demonstrated that 0.5-g
asal tension produced maximal KCl contraction.27 The
hanges in isometric contraction/relaxation were recorded
n a Grass polygraph (Model 7D; Astro-Med), as previ-
usly described.5
Control IVC contraction in response to 96-mM KCl
as first elicited. Once the KCl maximum contraction was
eached and a plateau achieved (within 10-15 minutes) the
issue was washed three times in Krebs, 10 minutes each.
he control contraction to 96-mM KCl was repeated twice
efore further experimentation.
To investigate the venous endothelial function, IVC
egments were precontracted with phenylephrine (Phe;
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June 20121718 Raffetto et al105 M) then treated with increasing concentrations
(1010 to 105 M) of Ach, and the percentage of venous
relaxation was measured. To test the role of the endothe-
lium, Ach-induced relaxation was compared in intact and
endothelium-denuded IVC. In these experiments, the endo-
thelium was mechanically removed by gently scraping the
intimal surface of the IVC segment five times around the tip of
forceps.5 To test the role of endothelium-dependent NO-
cGMP relaxation pathway, experiments were repeated in
IVC segments treated with the NO synthase (NOS) inhib-
itor L-NAME (3  104 M) and the guanylate cyclase
inhibitor 1H-1,2,4oxadiazolo[4,2-a]quinoxaline-1-one (ODQ;
105 M). To inhibit cyclooxygenase (COX), the veins were
pretreated for 10 minutes with indomethacin (105 M).
To test the role of hyperpolarization and potential release
of EDHF, the effects of Ach (105 M) were tested on vein
contraction induced by membrane depolarization by
96-mM KCl. To test for the potential K channel involved
in hyperpolarization, the effects of Ach on Phe-induced
IVC contraction were compared with those of the K
channel opener and KATP activator cromakalim (10
11 to
106 M). To further test for the specific K channel
involved, Ach-induced relaxation of Phe contraction was
examined in veins pretreated with the following K channel
blockers: nonselective blocker of Ca2-dependent K
channel tetraethylammonium (TEA; 103 M), KATP
blocker glibenclamide (105 M), KV blocker 4-aminopyridine
(4-AP; 103 M), SKCa blocker apamin (10
7 M), and
BKCa blocker iberiotoxin (10
8 M).3,5-8,16,28 The concen-
trations of inhibitors of NOS, COX, and K channels were
determined on the basis of previous studies and published
IC50.
Solutions, drugs, and chemicals. Normal Krebs so-
lution contained in mM: NaCl 120, KCl 5.9, NaHCO3 25,
NaH2PO4 1.2, dextrose 11.5 (Fisher Scientific, Fair Lawn,
NJ), CaCl2 2.5 (BDH Laboratory Supplies, Poole, Eng-
land), and MgCl2 1.2 (Sigma, St. Louis, Mo). Krebs solu-
tion was bubbled with 95% O2 and 5% CO2 for 30 minutes
at an adjusted pH 7.4. The 96-mM KCl was prepared as
normal Krebs but with equimolar substitution of NaCl with
KCl. Stock solutions of Phe (101 M), Ach (101 M),
L-NAME (101 M), 4-AP (101 M), apamin (103 M;
Sigma), and iberiotoxin (105 M) (Calbiochem, La Jolla,
Calif) were prepared in distilled water. TEA (Sigma) was
prepared as 1-mM solution in Krebs. Stock solutions of
1H-1,2,4oxadiazolo[4,2-a]quinoxaline-1-one (ODQ; 101;
Calbiochem), indomethacin (101 M), cromakalim (102
M), and glibenclamide (101 M; Sigma) were prepared in
diemtheylsulfoxide (DMSO). The final concentration of
DMSO in the experimental solution was 0.1%. All other
chemicals were of reagent grade or better.
Statistical analysis. Cumulative data were analyzed
and presented as means  SEM with the “n” value repre-
senting the number of experiments on different vein seg-
ments from four to 12 rats. Data were compared using
t-test for unpaired data and differences were considered
statistically significant if P  .05. IESULTS
Acetylcholine-induced endothelium-dependent relax-
tion. In endothelium-intact IVC, Phe (105 M) caused
ignificant contraction (0.07  0.01 g/mg tissue
eight) that was maintained at steady-state for appr-
ximately 20 minutes. Topical application of increas-
ng concentrations of Ach (109 to 105 M) caused
oncentration-dependent relaxation of Phe contraction
hat reached a maximum of 49.9  4.9% at 105 M. In
ndothelium-denuded IVC, Ach relaxation was completely
bsent (0.2 0.2%; P .001), indicating that the Ach-induced
ig 1. Acetylcholine (Ach)-induced relaxation in rat inferior vena
ava (IVC). Endothelium (Endo) intact IVC segments were pre-
ontracted with phenylephrine (Phe; 105 M), increasing Ach
oncentrations were added, the vein relaxation was observed (A),
nd the percentage of relaxation of Phe contraction was measured
B). In other experiments, the effects of Ach were measured in
ndothelium-denuded IVC (B). Data represent means  SEM
n  12-31). * Significant (P  .05).VC relaxation is endothelium-dependent (Fig 1).
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Pretreatment of IVC segments with the NOS blocker L-
NAME (3  104 M) caused a significant decrease in
Ach-induced relaxation to a maximum of 32.8 4.9% (P
.01) at 105 M. Also, pretreatment of IVC segments with
the guanylate cyclase inhibitor ODQ (105 M) caused
significant reduction of Ach relaxation to a maximum of
16.7  5.3% (P  .001) at 105 M (Fig 2). These data
indicated a role for NO-cGMP pathway in IVC relaxation.
However, Ach-induced relaxation was not completely in-
hibited by either L-NAME or ODQ, suggesting the in-
volvement of other venous relaxation pathways.
Contribution of prostacyclin and endothelium-
derived hyperpolarizing factor. To evaluate the role of
PGI2 in the Ach-induced relaxation observed during NO
blockade by L-NAME, veins were treated with the COX
inhibitor indomethacin (INDO; 105 M). Compared to
control Ach-induced relaxation (49.9  4.9%), in IVC
treated with both L-NAME  INDO, Ach caused signifi-
cantly less relaxation that reached a maximum of 33.6 
3.2% at 105 M (Fig 3). Ach-induced relaxation in the
presence of L-NAME INDO was not significantly differ-
ent from that in the presence of L-NAME alone, suggesting
little role of PGI2. In IVC treated with L-NAME  INDO 
nonselective Ca2 dependent K channel blocker TEA,
Ach-induced relaxation was abolished (0.5  0.3%), sug-
gesting a role of EDHF (Fig 3).
Effect of acetylcholine on KCl-induced contraction.
Fig 2. Role of nitrous oxide (NO)-cyclic guanosine monophos-
phate (cGMP) in acetylcholine (Ach)-induced relaxation of rat
inferior vena cava (IVC). IVC segments were either nontreated or
pretreated with N-nitro-L-arginine methyl ester (L-NAME; 3 
104 M) or oxadiazolo quinoxaline (ODQ; 105 M) for 15
minutes. IVC segments were then precontracted with phenyleph-
rine (Phe; 105 M), increasing Ach concentrations were added,
and the percentage of relaxation of Phe contraction was measured.
Data represent means SEM (n 8-31). * Significant (P .05).High 96-mM KCl depolarizing solution creates a K gra- cient that does not favor outward movement of K ion and
yperpolarization.25,29 KCl caused significant IVC con-
raction (0.27  0.02 g/mg tissue weight) that was main-
ained at steady-state for approximately 20 minutes.
ch caused concentration-dependent relaxation of KCl-
nduced contraction that reached a maximum of 59.5 
.5% at 105 M. In IVC treated with L-NAME  INDO,
ch-induced relaxation of KCl contraction was significantly
educed (5.7  1.0%; P  .0001; Fig 4). The absence of
ch-induced relaxation of KCl contraction in IVC treated
ith L-NAME  INDO suggests that any Ach-induced
DHF and hyperpolarization is blocked in the presence of
igh KCl depolarizing solution.
Effect of KATP channel opener cromakalim. The
rototype KATP channel activator cromakalim caused
oncentration-dependent relaxation of Phe contraction
hat reached a maximum of 91.0 1.6% at 106 M (Fig 5,
). In contrast, with Ach-induced relaxation of KCl con-
raction, cromakalim caused minimal relaxation of KCl-
nduced relaxation (3.1  1.3% at 106 M; Fig 5, B),
upporting that hyperpolarization is an important relax-
tion mechanism in IVC segments.
Interaction between nitrous oxide-dependent and
yperpolarization-dependent vein relaxation. In IVC
reated with L-NAME  INDO, Ach still caused signifi-
ant relaxation of Phe contraction, and addition of cro-
akalim (106 M) caused further relaxation of Phe con-
raction to 58.8  5.3% (P  .001; Fig 6). Because
ig 3. Contribution of nitrous oxide (NO), prostacyclin (PGI2),
nd endothelium-derived hyperpolarizing factor (EDHF) to ace-
ylcholine (Ach) relaxation of rat inferior vena cava (IVC). IVC
egments were either nontreated or pretreated with N-nitro-L-
rginine methyl ester (L-NAME; 3 104 M) plus indomethacin
INDO; 105 M) or L-NAME  INDO  tetraethylammonium
TEA; 103 M) for 15 minutes. IVC segments were then precon-
racted with phenylephrine (Phe; 105 M), increasing Ach concen-
rations were added, and the percentage of relaxation of Phe
ontraction was measured. The L-NAME-sensitive component of
ch relaxation (35%) is attributed to NO, whereas the TEA-
ensitive component (65%) is attributed to EDHF. Data repre-
ent means  SEM (n  16-31). * Significant (P  .05).romakalim activates KATP, its additive effects to maximal
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channels other than KATP. In comparison, in IVC treated
with L-NAME  INDO, cromakalim caused relaxation of
Phe contraction (61.0  4.6%), but was unexpectedly less
than the relaxation caused by cromakalim alone (91.0 
1.6%), suggesting cross-talk between the NO-cGMP and
hyperpolarization pathways. On the other hand, Ach did not
cause any further significant relaxation of Phe contraction in
veins treated with cromakalim in the presence of L-NAME
INDO (Fig 6), likely due to cromakalim-induced maximal
hyperpolarization.
Effect of selective K channel blockers. Ach could
use one or more K channel to produce IVC hyperpolar-
ization.8,16-18 In order to determine the K channel(s)
involved in the IVC relaxation, selective K channel block-
ers were used. Compared to control Ach-induced relax-
ation, Ach-induced relaxation was not significantly reduced
in IVC treated with KATP blocker glibenclamide, Kv
blocker 4-AP, or SKCa blocker apamin. In contrast, Ach-
induced relaxation was significantly reduced in IVCs
treated with the BKCa blocker IbTx (Fig 7).
DISCUSSION
The present findings in rat IVC demonstrate that: (1)
Ach causes significant endothelium-dependent venous re-
Fig 4. Contribution of nitrous oxide (NO), prostacyclin (PGI2),
and endothelium-derived hyperpolarizing factor (EDHF) to ace-
tylcholine (Ach) relaxation of depolarization-induced contraction
of rat inferior vena cava (IVC). IVC segments were either non-
treated or pretreated with N-nitro-L-arginine methyl ester (L-
NAME; 3 104 M) plus indomethacin (INDO; 105 M) for 15
minutes. IVC segments were then precontracted with high KCl
(96 mM) depolarizing solution, increasing Ach concentrations
were added, and the percentage of relaxation of KCl contraction
was measured. The L-NAME-sensitive component of Ach relax-
ation of KCl contraction (95%) is attributed to NO, and almost
no relaxation is attributed to EDHF. Data represent means SEM
(n  12). * Significant (P  .05).laxation; (2) approximately one-third of Ach-induced ve- wous relaxation involves NO synthesis and the NO-cGMP
athway; (3) hyperpolarization is an important mechanism
f venous relaxation; (4) approximately two-thirds of Ach-
nduced venous relaxation involves activation of BKCa-
ependent hyperpolarization pathway; and (5) there is a
ross-talk between the hyperpolarization-dependent and
O-cGMP pathways during vein relaxation.
Several groups have examined endothelium-dependent
elaxation in numerous arterial preparations.30-33 However,
ur knowledge regarding the endothelium-dependent ve-
ous relaxation pathways is limited.24-26 This is in part
ecause the venous tissue is very delicate and difficult to
andle. We have previously shown that the rat IVC pro-
uces significant and measurable contraction.5,34 Consis-
ent with our previous reports, we found that the rat IVC
roduced significant Phe contraction. The Phe contraction
as maintained for at least 20 minutes, making it possible
o measure Ach-induced vein relaxation.
Consistent with previous reports in arterial segments,35,36
ch-induced IVC relaxation was concentration dependent and
eached a maximum at 105-M concentration. Also, the
agnitude of Ach-induced venous relaxation (50% to 60%)
as in the range of Ach-induced relaxation in arterial
egments. Ach-induced venous relaxation was endothelium de-
endent because it was nearly abolished in endothelium-
enuded veins. Our results are consistent with an earlier
tudy demonstrating endothelium-dependent relaxation in
at femoral veins.25 These observations suggest that the
enous endothelium is functional and produces significant
elaxation of venous tissue.
The endothelium is known to release several vasodi-
ator substances, including NO, PGI2, and EDHF.
5-8
ndothelial-derived vasodilators are released in response
o shear stress acting on endothelial cells, and also in
esponse to neurohumoral mediators in the circulation
cting on specific receptors on the endothelium, includ-
ng growth factors, cathecholamines, histamine, Ach,
rachidonic acid, bradykinin, serotonin, thrombin, en-
othelin, arginine vasopressin, and adenosine diphos-
hate released by aggregating platelets.8 In large blood
essels such as the aorta, pharmacologic inhibitors of
OS and COX almost abolish Ach-induced relaxation.
n contrast, in small resistance arteries pretreated with
OS and COX inhibitors, a significant component of
ch-induced relaxation is still observed, suggesting a
ole of EDHF in the regulation of arterial tone.1,8
Endothelium-derived NO is known to diffuse into
ascular smooth muscle (VSM) where it activates guanylate
yclase and increases cGMP production. cGMP activates
GMP-dependent protein kinase (PKG), which promotes
a2 extrusion and decreases VSM [Ca2]i and also causes
hosphorylation and inactivation of myosin light chain
inase leading to inhibition of VSM contraction and con-
equent vascular relaxation.11,13 We have previously shown
hat the rat IVC produces significant amounts of NO under
asal conditions and that Ach produces significant increases
n NO production.5 Consistent with our previous report,
e found that Ach-induced IVC relaxation was partly
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Volume 55, Number 6 Raffetto et al 1721blocked by the NOS inhibitor L-NAME. Also, inhibition
of guanylate cyclase by ODQ caused significant decrease in
Ach-induced relaxation, indicating the importance of NO-
Fig 5. Contribution of hyperpolarization pathway to re
precontracted with either phenylephrine (Phe; 105 M)
segments were then treated with increasing concentration
channel activator cromakalim, or acetylcholine (Ach) fo
caused larger relaxation of Phe-induced contraction, but
tion. Data represent means  SEM (n  8-31).
Fig 6. Interaction between nitrous oxide (NO)-dependent and hyper-
polarization-dependent relaxation in rat inferior vena cava (IVC). IVC
segments were precontracted with phenylephrine (Phe; 105 M) and a
control acetylcholine (Ach; 105 M) or cromakalim (106 M) relaxation
was elicited (open bars). In parallel experiments, IVC segments were
pretreated with N-nitro-L-arginine methyl ester (L-NAME; 3 10
4
M)  indomethacin (INDO; 105 M) for 15 minutes, precontracted
with Phe, then treated with Ach (105 M) or cromakalim (106 M;
dotted bars). At steady-state, the veins treated with Ach were further
challenged with cromakalim, whereas the veins treated with cromakalim
were further challenged with Ach, and the veins were observed for any
further relaxation (solid bars). Cromakalim caused further relaxation of
Ach-treated veins, while Ach did not cause any further significant relax-
ation of cromakalim-treated veins. Data represent means  SEM (n 
7-31). *Measurements in L-NAME INDO treated veins are signifi-
cantly different (P .05) from corresponding measurements in control
veins. #Measurements in veins treated with L-NAME INDO Ach
followed by cromakalim are significantly different (P .05) from corre-
sponding measurements in control veins.cGMP pathway in venous relaxation.1,37,38 However, a cignificant Ach-induced relaxation could still be observed in
-NAME-treated IVC, suggesting the involvement of
ther endothelium-derived relaxing factors (EDRFs). Pre-
reatment of IVC with L-NAME plus the COX inhibitor
NDO did not cause any further reduction in Ach-induced
elaxation, suggesting little role of PGI2. This study in rat
VC demonstrated that one-third of Ach relaxation was due
o NO, and by excluding PGI2, the remaining two-thirds of
ch-induced relaxation seem to involve EDHF. One way
o block EDHF is to use high KCl depolarizing solution,
hich creates a K gradient that does not favor outward
ovement of the K ion and, therefore, prevents hyperpo-
arization.25,29 Ach caused approximately 60% relaxation of
Cl contraction, that was abolished in IVC treated with
-NAME  INDO, further supporting a role of the NO-
GMP pathways. Importantly, in IVC treated with both
-NAME and INDO, Ach still caused relaxation of Phe
ontraction, but failed to cause relaxation of KCl contrac-
ion. These data support a role of EDHF in Ach-induced
elaxation and that this hyperpolarization factor is blocked
n the presence of KCl depolarizing solution. These data
lso support that EDHF is an important pathway, in not
nly the regulation of arterial tone,25,26 but also the regu-
ation of venous function.
Although the exact nature of the EDHF molecules is
ot exactly known, several candidate compounds have been
tudied and likely function as EDRF and lead to hyperpo-
arization. Potassium ions are known to accumulate in the
ntercellular space between endothelial and smooth muscle
ells (SMCs). The potassium ions form what is called a
otassium cloud that activates SKCa and IKCa on the endo-
helium and hyperpolarization ensues by activating both
IR and Na
/K pump on the SMC.10 Other important
DHFs are metabolites of arachidonic acid produced by
ion of rat inferior vena cava (IVC). IVC segments were
or high KCl (96 mM) depolarizing solution (B). IVC
he adenosine triphosphate-sensitive K channels (KATP)
parison. Compared to the Ach response, cromakalim
st no relaxation of depolarization-induced KCl contrac-laxat
(A)
s of t
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June 20121722 Raffetto et alcosatrienoic (EET) acid.39 EETs are known to hyperpolar-
ize smooth muscle by activating BKCa and other K
 chan-
nels.40 Other EDHF candidates are hydrogen peroxide
that may activate K channels on the endothelium or
SMC,15 but the mechanism is unclear. Additionally, C-type
natriuretic peptide leads to hyperpolarization of both arte-
rial and venous tissue by activating BKCa.
8,26
The current study was not intended to characterize the
EDHF molecule, but to highlight the role of hyperpolar-
ization and potential K channel(s) involved in IVC relax-
ation. There are several K channel openers that include
cromakalim, pinacidil, nicorandil, diazoxide, and RP-
49356.29 Cromakalim works mainly by activating KATP
channels.41 Our data demonstrate significant IVC relax-
ation in response to cromakalim, supporting a role of
hyperpolarization and activation of KATP channels as a
major mechanism of IVC relaxation. This is consistent with
other studies demonstrating a significant relaxation to cro-
makalim in human saphenous vein.42,43 Importantly, the
venorelaxant effect of cromakalim was essentially abolished
in IVC precontracted with 96-mM KCl. High KCl solution
abrogates the outward flow of K from the endothelium
and SMC via K channels, and, hence, completely elimi-
nates the possibility for hyperpolarization and relaxation.
Our findings are consistent with previous reports in both
rat and human venous tissues.25,42
In search for the potential K channel involved in IVC
relaxation, we found that Ach-induced relaxation was not
reversed in the presence of specific blockers of KATP, KV, or
SKCa. In contrast, Ach-induced IVC relaxation was abol-
ished in the presence of the BKCa blocker iberiotoxin.
These findings suggest that a key modulator of hyperpolar-
ization in the IVC venous system is via the activation of
BK channel. Our data are consistent with reports that
Fig 7. Effect of selective K channel blockers on acetylcholine
(Ach) relaxation of rat inferior vena cava (IVC). IVC segments
were precontracted with phenylephrine (Phe; 105 M) and a
control Ach (105 M)-induced relaxation was elicited. At steady-
state, the veins were treated with a specific K channel blocker:
adenosine triphosphate-sensitive K channels (KATP) blocker glib-
enclamide (105 M), KV blocker 4-aminopyridine (4-AP; 10
3
M), SKCa blocker apamin (10
7 M), and BKCa blocker iberiotoxin
(IbTX; 108 M), and the remaining Ach relaxation was measured.
Data represent means SEM (n 4-31). *Measurements in veins
treated with K channel blocker are significantly different (P 
.05) from corresponding measurements in control veins.Ca
human umbilical vein endothelial cells express BKCa.
44 uhus, although in the arterial system, EDHF may require
he activation of SKCa and also IKCa to cause hyperpolar-
zation,3,8,45,46 this may not be the situation in veins,
articularly the IVC.
NO not only activates guanylate cyclase to produce
GMP, but can also coactivate various K channels, includ-
ng KATP, KV, and BKCa.
1,8 In porcine internal mammary
nd rat mesenteric arteries, Ach-induced relaxation via the
O-cGMP pathway could also involve activation of SKCa,
KCa, and KV channels.
37,47 We found that cromakalim
aused less relaxation in the presence of L-NAME and
NDO than cromakalim alone. This would indicate that
O, either directly or indirectly via increasing cGMP, is an
mportant effector molecule in enhancing KATP channel
ctivity during hyperpolarization and relaxation of rat IVC
Fig 8).
It is important to note that the present study was
onducted on rat IVC. Although the rat IVC is a very
hin and delicate preparation, we have perfected the vein
arvesting and dissection technique and obtained repro-
ucible data and consistent findings.5,27,48,49 Our tissue
istology studies demonstrate that, similar to human
eins, the rat IVC has three anatomical layers; intima,
edia, and adventitia.34 Also, physiologic vein function
tudies demonstrate that the rat IVC contract and relax
o various constrictor and vasodilator stimuli.5,49 Al-
hough the rat is a four-legged animal, studies on rat
issues avoid variability in age, body weight, and other
onfounding factors in humans. To enhance the rele-
ance of the present findings to lower extremity veins,
tudies should be conducted on rat iliac and femoral
ein. However, because human lower extremity veins are
ubjected to more pressure in the upright posture and
ay adapt differently to pressure/stretch, one needs to
e careful in extrapolating the present data in rat veins to
uman veins. We have previously studied vein functions
n circular segments of human saphenous veins and
aricose veins.50 We have shown that membrane depo-
arization by high 96-mM KCl solution causes significant
ontraction of human saphenous veins. Whether mem-
rane hyperpolarization plays a role in human vein relax-
tion is unclear and should represent an important area
or future investigations. Furthermore, to enhance the
ranslational aspects, future studies should characterize
ot only the relaxation pathways in control greater sa-
henous veins but also the changes in the venous relax-
tion mechanisms in varicose veins.
Venous wall disease could take several forms ranging
rom vein restenosis and graft failure51 to venous dilation
nd varicose veins.52 Dilated varicose veins, both primary
nd recurrent, are known to involve valve dysfunction
ith increased venous pressure leading to wall dilation
nd refluxing valves in any segment of the superficial and
eep system.53 However, venous wall dilation could also
recede valve dysfunction and may have an equally im-
ortant role in the pathophysiology of varicose vein
evelopment.52,54 The identification of the mechanisms
nderlying venous relaxation could be important in un-
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ing the vein wall stenosis associated with graft failure and
vein wall dilation associated with varicose vein forma-
tion. Targeting these abnormal venodilator mechanisms
could be useful in the management of venous disease.
Pharmacologic activators of the NO pathway and K
channels could be useful in reducing vein restenosis and
graft failure. On the other hand, pharmacologic therapy
using specific inhibitors of the NO pathway and specific
K channel blockers could be useful in the management
of primary and recurrent varicose veins.
Vein valvular disease has been suggested to cause
vein reflux and subsequent venous dilation. However,
venous wall duplex ultrasonographic studies have de-
scribed an ascending phenomenon to the pathophysiol-
ogy of varicose veins, suggesting that vein wall dilation
may precede valvular dysfunction.52 Also, biochemical
abnormalities similar to those observed in varicose veins
have been demonstrated in normal-appearing human
saphenous vein wall adjacent to varicose veins and be-
tween competent venous valves.55,56 We have also
shown that prolonged increases in vein wall tension in rat
IVC is associated with venous dysfunction and decreased
vein contraction.27 The increased vein wall tension
causes an increase in matrix metalloproteinases
(MMP)-2 and MMP-9, and MMPs in turn cause vein
wall hyperpolarization and venous relaxation possibly by
activating large conductance Ca2-dependent K chan-
Fig 8. Venous relaxation pathways in rat inferior vena
(NO)-cyclic guanosine monophosphate (cGMP) pathwa
hyperpolarization and further vein relaxation. Cromak
channels (KATP) causing hyperpolarization and vein rela
activity via a cross-talk mechanism.BKCa, Large conducta
hyperpolarizing factor; eNOS, endothelial nitric oxide synels.5 MMP-2-induced hyperpolarization could cause tnhibition of Ca2 entry into venous smooth muscle.34
he present study supports the contention that hyperpo-
arization is a major relaxation pathway in veins. We
ostulate that persistent and recalcitrant venous hyper-
ension leads to increased vein wall tension and release of
MP-2 and MMP-9, which in turn cause hyperpolariza-
ion and inhibition of Ca2 entry into venous smooth
uscle and leads to decreased contraction and the in-
reased venous dilation associated with varicose veins.27
t is likely that both valve dysfunction and vein wall
ilation play a role in the pathophysiology of varicose
eins. Thus, while removing reflux would lead to remod-
ling and “shrink down” of varicose veins in humans, it
ould also remove the persistent venous hypertension
nd the increased vein wall tension. This will in turn
everse the increase in MMPs, and the persistent vein
all hyperpolarization and the venous dilation associated
ith varicose veins.
In conclusion, the present study elucidated some of
he mechanisms involved in relaxation of rat IVC. Im-
ortantly, venous relaxation involves endothelium-de-
endent pathways that are mediated by both NO-cGMP
nd EDHF, with an important contribution of hyperpo-
arization via BKCa and KATP channels. Further research
ill be required to determine the role of NO-cGMP,
GI2-cAMP, and EDHF relaxation pathways in human
aphenous veins and varicose veins and to examine po-
ential pharmacologic interventions that can be useful in
IVC). Acetylcholine (Ach) stimulates the nitrous oxide
ause vein relaxation. Ach also activates BKCa leading to
activates adenosine triphosphate (ATP)-sensitive K
. NO-cGMP could directly or indirectly enhance KATP
a2-activated K channel; EDHF, endothelium-derived
e; VSMC, vascular smooth muscle cell.cava (
y to c
alim
xation
nce Che treatment of the overdistended varicose veins.
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